Zhang et al. [15] found that IFN-αspecifically blocked the proliferation advantage of JAK2V617F mutant hematopoietic stem cells in mice, thereby preventing the development of MPN and even achieving eradication [16]. Here, IFNA1 is linked to myeloproliferative neoplasm.